$BIVI
Biovie Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Carson City, NV
BIVI chart
What traders are saying about $BIVI
Latest postsBiovie Inc. news
- Novel drug bezisterim plans for further study in Long COVID. Here’s how the phase 2 trial came together.
The Sick Times ·
- Experimental Parkinson's therapy shows promise in Phase 2 study
Parkinson's News Today ·
- BioVie Inc. Estimates – NASDAQ:BIVIW
TradingView ·
- BioVie Inc. (BIVI) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Small cap wrap: BioVie, Nextech3D.AI, Pinnacle Silver and Gold, Trust Stamp...
Proactive financial news ·
- Market movers: SpaceX, Tesla, Verizon, BioVie...
Proactive financial news ·
- Comscore to Announce Third Quarter 2026 Financial Results
The Manila Times ·
- Timbercreek Financial to Release Q3 2026 Results November 11; Conference Call Scheduled November 12
The Manila Times ·
- Seismic Therapeutic to Participate in Upcoming Investor Conferences
The Manila Times ·
- Certara to Report Third Quarter 2026 Financial Results on November 5th, 2026
The Manila Times ·
- Stryker completes acquisition of ZuriMED to enhance its shoulder offering
The Manila Times ·
- BioVie Invited to Present Data on Bezisterim in Long COVID at the NIH’s RECOVER-TLC Third Annual Workshop
Yahoo Finance ·
Biovie Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net income | -$22.1M | -$17.5M | -$32.1M | -$50.3M |
| Diluted EPS | $-3.05 | $-12.12 | $-73.05 | $-15.47 |
| Total assets (year end) | – | $22.5M | $25.7M | $21.5M |
| Cash and equivalents (year end) | – | $20.5M | $24.4M | $20.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- DEF 14ADEF 14A
- 8-KCURRENT REPORT
- 10-KFORM 10-K FOR PERIOD ENDED JUNE 30, 2026
- 8-KCURRENT REPORT
- S-1FORM S-1 REGISTRATION STATEMENT
- 10-QFORM 10-Q FOR PERIOD ENDING MARCH 31, 2026
- 10-QFORM 10-Q FOR PERIOD ENDING DECEMBER 31, 2025
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QFORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2025
- DEF 14ADEF 14A
- 10-KFORM 10-K
About Biovie Inc.
- Ticker
- BIVI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Carson City, NV
- Incorporated in
- NV
- Fiscal year end
- June 30
- SEC CIK
- 1580149
- Former names
- NANOANTIBIOTICS, INC.
Frequently asked questions
What exchange is Biovie Inc. listed on?
Biovie Inc. trades on the Nasdaq under the ticker symbol BIVI.
What industry is Biovie Inc. in?
Biovie Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Biovie Inc. headquartered?
Biovie Inc.'s business address on file with the SEC is in Carson City, NV.
When does Biovie Inc.'s fiscal year end?
Biovie Inc.'s fiscal year ends on June 30.